Patients share their experiences with myeloma relapses, discussing coping strategies, emotional challenges, and the ...

A new Curtin University study has found that people diagnosed with sarcoma—a cancer disproportionately affecting teenagers and young adults—are being left without the resources they urgently need.

At the American Society of Hematology Conference in Orlando, new results from the MajesTEC-3 study show that combining teclistamab with daratumumab could help people with myeloma whose cancer has come ...

Staging is when a system is used to identify and describe how far a cancer has spread in your body. Knowing the stage of your multiple myeloma helps your physicians predict which treatments are most ...

It’s important to know that at first, multiple myeloma may not cause any symptoms. Usually, it is only suspected after a routine blood test shows an abnormality. After the disease has progressed, ...

WHITE BLUFF, Tenn. (WKRN) — White Bluff has been dealing with a week of smoke and a strong odor in some parts of town that just won’t let up. This came after someone left a massive load of mulch ...

THURSDAY, Nov. 13, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent treatment for adult patients with ...

The FDA on Thursday approved daratumumab-hyaluronidase (Darzalex Faspro) as the first drug for high-risk smoldering multiple myeloma. Approval of the subcutaneous daratumumab product was based on ...

(RTTNews) - Halozyme Therapeutics, Inc. (HALO), Friday announced that Johnson & Johnson has received U.S. Food and Drug Administration approval of a new indication for DARZALEX Faspro as a single ...

The U.S. Food and Drug Administration (FDA) approved on Thursday Johnson & Johnson’s (NYSE:JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for a type of blood cancer. Darzalex Faspro is the ...

SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Johnson & Johnson received U.S. Food and Drug Administration (FDA) approval of a new ...